Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management.

Related Articles

Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management.

J Clin Tuberc Other Mycobact Dis. 2017 Dec;9:10-18

Authors: Chandrashekaran S, Escalante P, Kennedy CC

Abstract
Mycobacterium abscessus complex (MAbsC ) disease in lung transplant recipients is increasingly being recognized as an important cause of graft function decline and suboptimal outcomes. Lung transplant recipients appear to be at the highest risk of MAbsC among solid organ transplant recipients, as they have more intense immunosuppression, and the organisms preferentially inhabit the lungs. MAbsC is the most resistant species of rapidly growing mycobacteria and difficult to treat, causing considerable mortality and morbidity in immunocompetent and immunosuppressed patients. Herein we describe the risk factors, epidemiology, clinical features, diagnostics, and treatment strategies of MAbsC in lung transplant recipients.

PMID: 29276785 [PubMed]

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kZIQUt
via IFTTT